Abstract: In an embodiment an X-ray source includes an electron source configured to emit electrons, an acceleration set-up configured to accelerate the emitted electrons and a transmission window downwards of the acceleration set-up, wherein the transmission window is configured to let through X-rays generated by the accelerated electrons, wherein the transmission window is located either in a straight extension of a line-of-flight of the accelerated electrons or off the line-of-flight and past the acceleration set-up, wherein the transmission window comprises a carbon carrier, and wherein the carbon carrier comprises sp2-hybridized carbon.

Abstract: In at least one embodiment an X-ray source includes an electron source configured to emit electrons, an acceleration set-up configured to accelerate the emitted electrons and a transmission window downwards of the acceleration set-up, the transmission window configured to let through X-rays generated by the accelerated electrons, wherein the transmission window incudes a carbon carrier, and wherein the carbon carrier includes sp2-hybridized carbon.

Abstract: A method for regulating a kinematic variable of a motor vehicle. The method includes: receiving actual value signals, which represent an actual value of a kinematic variable of a motor vehicle; receiving setpoint signals, which represent a setpoint value of the kinematic variable; ascertaining an actuating variable to be implemented by one or multiple actuating element(s) of the motor vehicle, based on the actual value, the setpoint value and a variation of the setpoint value over time in such a way that a deviation between the actual value and the setpoint value becomes smaller when the actuating variable is implemented with the aid of the one or multiple actuating element(s); and outputting actuating variable signals, which represent the ascertained actuating variable. A device, a computer program, and a machine-readable memory medium are also described.

Abstract: In an embodiment a filter system includes a fluid channel configured to guide a fluid to be separated into at least two constituents, an ionizer in or at the fluid channel, the ionizer configured to at least partially ionize the fluid into ions, and a separation unit in or at the fluid channel, the separation unit arranged downstream of the ionizer and configured to separate the at least two constituents from one another and to guide them separately from one another.

Abstract: In an embodiment an ionization detector includes a gate-insulator-substrate electron-emission structure (GIS-EE) configured to emit low-energy electrons, a sample chamber configured for at least one gas to be detected, the sample chamber being adjacent to the GIS-EE and a measuring unit configured to detect and/or select charged particles, wherein the charged particles are due to the emitted electrons and/or comprise the emitted electrons.

Abstract: A method includes displaying, on a GUI, a graphical representation of a geographical area sectioned into a plurality of subareas defined by boundaries; displaying, over the graphical representation, a resource need layer that visually depicts a first parameter associated with a need of a resource within a subarea, the depiction of the first parameter varying within the subarea; and displaying, over the graphical representation, a resource availability layer that visually depicts a second parameter indicating the availability of the resource within the subarea, the depiction of the second parameter varying within the subarea; wherein the layers are displayed simultaneously over the graphical representation to provide a visual comparison of the need of the resource and the availability of the resource within the subarea. In some embodiments, the need is based on data including one or more of demographic data from a census, other data from the census, and crime data.

Abstract: This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: A method for regulating a kinematic variable of a motor vehicle. The method includes: receiving actual value signals, which represent an actual value of a kinematic variable of a motor vehicle; receiving setpoint signals, which represent a setpoint value of the kinematic variable; ascertaining an actuating variable to be implemented by one or multiple actuating element(s) of the motor vehicle, based on the actual value, the setpoint value and a variation of the setpoint value over time in such a way that a deviation between the actual value and the setpoint value becomes smaller when the actuating variable is implemented with the aid of the one or multiple actuating element(s); and outputting actuating variable signals, which represent the ascertained actuating variable. A device, a computer program, and a machine-readable memory medium are also described.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: A device for generating a source current of charge carriers and a method for stabilizing a source current of charge carriers are disclosed. In an embodiment the device includes at least one field emission element configured to emit charge carriers, which lead to an emission current in the field emission element, at least one extraction electrode configured to apply an extraction voltage in order to extract the charge carriers from the field emission element, wherein a first part of the extracted charge carriers contributes to the source current, and a second part of the extracted charge carriers impinges on the extraction electrode and leads to an extraction current in the extraction electrode and a control device configured to reduce fluctuations of a controlled variable Q which is a characteristic for the source current, wherein Q is a function of a difference between the emission current and the extraction current.

Abstract: This invention provides an antibody or functional antibody fragments, or probe thereof directed against a unique group of antigens identified in cancer. The present invention comprises nucleotide sequences derived from L2A5 monoclonal antibody. The antibody or functional antibody fragment, or probe thereof includes a variable heavy chain domain and a variable light chain domain that has an amino acid sequence provided herein. This DNA/amino acid sequence conjugation is unique and has never been described before. The present invention further provides antibody or functional antibody fragment or a conjugate or a recombinant protein useful in the detection, treatment and prevention of human disease, including cancer.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: A device for generating a source current of charge carriers and a method for stabilizing a source current of charge carriers are disclosed. In an embodiment the device includes at least one field emission element configured to emit charge carriers, which lead to an emission current in the field emission element, at least one extraction electrode configured to apply an extraction voltage in order to extract the charge carriers from the field emission element, wherein a first part of the extracted charge carriers contributes to the source current, and a second part of the extracted charge carriers impinges on the extraction electrode and leads to an extraction current in the extraction electrode and a control device configured to reduce fluctuations of a controlled variable Q which is a characteristic for the source current, wherein Q is a function of a difference between the emission current and the extraction current.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: A device for generating a source current of charge carriers by a field emission and a method stabilizing a source current of charge carriers emitted by a field emission element are disclosed. In an embodiment the device includes at least one field emission element from which the charge carriers emerge during operation, which lead to an emission current in the field emission element, at least one extraction electrode in order to extract the charge carriers from the field emission element, wherein a first part of the extracted charge carriers contributes to the source current, and a second part of the extracted charge carriers impinges on the extraction electrode and leads to an extraction current in the extraction electrode, an additional electrode on which the source current of charge carriers impinges at least in part and which contributes to an electrode current in the additional electrode.

Abstract: The present invention relates to immune cell-based anti-cancer therapeutics and methods of using the therapeutics in the treatment of cancer.

Abstract: The invention relates to antibodies against the human La protein and to their use in immunotargeting, in particular the immunotargeting of tumor cells. The object of the invention is to provide improved antibodies which bind universal target structures on the surface of tumor cells, and to provide novel anti-La antibodies, in particular with a high affinity for La, a universal target structure on tumor cells, which make it possible to use the antibodies as recombinant fragments for immunotargeting. The invention comprises recombinant antibodies comprising: (i) a binding unit of an antibody which specifically binds to an epitope of a human nuclear antigen, preferably human La protein, and (ii) a binding unit of an antibody which specifically binds to an effector cell or of a ligand which specifically binds to an effector cell. The invention furthermore comprises novel antibodies which specifically bind the human La protein.

Abstract: A receptacle holding unit includes a first part and a second part cooperating with the first part; a cavity for receiving a receptacle containing an ingredient for preparing a beverage by a device, the cavity being delimited by at least one of the first and second parts; and a driving device for relatively moving the second part towards the first part into a closed position and relatively apart from the first part into an open position. The driving device includes an actuator and a transmission having a helicoidal ramp arrangement cooperating with a connector member for converting a translational movement into a rotational movement or vice versa. When the actuator actuates the transmission, the first and second parts are driven together or apart. The ramp arrangement includes two ramps spaced apart and generally parallel between which the connector member relatively moves along the ramp arrangement.